SUSAN CAULKINS: Open Payments
NPI 1518160431 · MANNING, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$759 in 33 payments from 14 companies in 2025. Trend: 2023 $399 · 2024 $744 · 2025 $759
Food & beverage: $759
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $204 |
| Dexcom, Inc. | 3 | $105 |
| Novartis Pharmaceuticals Corporation | 5 | $83 |
| ABBVIE INC. | 4 | $79 |
| Amgen Inc. | 3 | $56 |
| Novo Nordisk Inc | 2 | $44 |
| Exact Sciences Corporation | 2 | $34 |
| Phathom Pharmaceuticals, Inc. | 2 | $27 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $25 |
| Astellas Pharma US Inc | 1 | $25 |
Products named: FARXIGA, Dexcom G6 Transmitter, LEQVIO, VRAYLAR, OTEZLA, Cologuard Collection Kit, BREZTRI, VOQUEZNA.
Industry payments across SC — which companies pay providers there.
